Infection Surveillance Solutions Market Size, Share & Industry Analysis, By Component (Software and Services), By Surveillance Type (HAI Surveillance, AMR & Stewardship, Outbreak Detection & Response, and Post-discharge), By Deployment (Cloud / SaaS and On-premise), By End User (Acute Care Hospitals, Private Hospital Networks, Long-term Care, and Diagnostic Labs & Others), and Regional Forecast, 2026-2034

The global infection surveillance solutions market size was valued at USD 939.6 million in 2025. The market is projected to grow from USD 1,040.1 million in 2026 to USD 2,381.8 million by 2034, exhibiting a CAGR of 10.91% during the forecast period.

The global infection surveillance solutions market is a critical segment of healthcare information technology focused on monitoring, detecting, and preventing Healthcare-Associated Infections (HAIs) and infectious disease outbreaks. Infection surveillance solutions combine software platforms, analytics, and data integration to support hospitals and public health agencies in improving patient safety and regulatory compliance. This market is witnessing a strong growth driven by the increasing prevalence of healthcare-associated infections along with other factors.

Various key industry players, such as Premier Inc., Oracle, BD, and others are focusing on innovative product offerings to maintain their market presence, in turn shaping the overall market.

INFECTION SURVEILLANCE SOLUTIONS MARKET TRENDS

Increasing AI/ML Adoption is a Significant Trend Observed in Market

In recent years, AI/ML is increasingly embedded in infection surveillance platforms to automate HAI case-finding and flag at-risk patients earlier than manual chart review. Also, predictive models are being used to prioritize which patients, units, and devices need infection-prevention attention first helping stretched IP teams focus on the highest-yield investigations.  These factors are supporting the overall global market growth.

• For instance, in April 2025, the University of Pittsburgh highlighted EDS-HAT, which uses machine learning along with genomic sequencing to detect hospital transmission patterns and guide infection-prevention action.

Download Free sample to learn more about this report.

MARKET DYNAMICS

MARKET DRIVERS

Increasing Prevalence of Healthcare-associated Infections is Propelling Market Growth

Increasing prevalence of healthcare-associated infections is significantly drives the global infection surveillance solutions market growth. Healthcare-associated infections (HAIs) remain highly prevalent across care settings, increasing the urgency for hospitals and long term care facilities to detect, contain, and report infections faster in turn fueling demand for infection surveillance solutions. As patient acuity rises and invasive device use continues, facilities need continuous, automated surveillance to spot CLABSI/CAUTI/SSI/C. difficile signals early and reduce outbreak risk. All these factors cumulatively drive the overall market growth.

• For instance, in May 2025, ECDC highlighted HAIs as a major threat in European long-term care facilities and reiterated that >3.5 million HAI cases are estimated annually in the EU/EEA.

MARKET RESTRAINTS

High Implementation Costs and Limited IT Resources to Hamper Market Growth

High implementation costs and limited IT resources are key restraints for the infection surveillance solutions market, as advanced systems require significant upfront investment in software, hardware, EHR integration, and ongoing maintenance burdens that many facilities, especially smaller or resource-constrained ones, struggle to absorb. In addition, budget constraints often force healthcare providers to prioritize immediate clinical needs over digital surveillance tools, slowing adoption and delaying modernization of infection-control workflows. This results in limiting the market growth to certain extent.

MARKET OPPORTUNITIES

Rising Focus on Antimicrobial Resistance Monitoring to Offer Market Growth Opportunities

Rising focus on Antimicrobial Resistance Monitoring (AMR) is a major market opportunity. AMR monitoring is becoming an important metric for hospitals, creating strong demand for infection surveillance tools that can continuously analyze microbiology results, resistance phenotypes, and antibiotic use patterns. Providers increasingly want integrated AMR + HAI surveillance so they can detect resistant organisms early, spot clusters, and trigger isolation/stewardship workflows faster. The opportunity is biggest for vendors that can deliver standardized, comparable analytics across sites to support quality committees and AMR programs. All these factors would drive the market growth in the coming years.

• For instance, in September 2025, WHO launched an enhanced GLASS AMR/AMU dashboard, strengthening global AMR monitoring and increasing demand for hospitals/countries to digitize and report usable AMR/antibiotic-use data.

MARKET CHALLENGES

Integration Complexity with Electronic Health Records (EHRs) Pose a Critical Challenge to Market Growth

Integration Complexity with Electronic Health Records (EHRs) remain a significant challenge in this market. This is since these platforms must reliably pull ADT, microbiology, meds, devices, and clinical documentation from systems that vary widely by site and configuration. In addition, when hospitals have interfaces, data often arrives in different formats/codes, requiring mapping, normalization, and ongoing maintenance whenever the EHR workflow, lab system, or interface engine changes. All the factors cumulatively affect the market growth.

Segmentation Analysis

By Component

Higher Adoption by Hospitals and Higher Efficiency to Propel Software Segmental Growth

Based on the component, the market is divided into software and services.

The software segment is expected to dominate the global infection surveillance solutions market share. The dominance can be attributed to higher adoption by hospitals, higher efficiency, and shift toward cloud-based delivery.  Additionally, strategic initiatives by operating players through partnerships also boosted the segment growth.

• For instance, in February 2024, Inovalon acquired VigiLanz, a SaaS-based clinical surveillance and patient safety software company to strengthen its market presence.

The services segment is anticipated to rise with a CAGR of 9.88% over the forecast period.  

To know how our report can help streamline your business, Speak to Analyst

By Surveillance Type

Foundational Role in Infection Surveillance Supported HAI Surveillance Segmental Dominance

Based on the surveillance type, the market is divided into HAI surveillance, AMR & stewardship, outbreak detection & response, and post-discharge.

The HAI surveillance segment is expected to account for the largest global market share. Factors supporting the segment dominance include its fundamental role in detection of infections in hospitals.  It has the broadest addressable scope so it drives the largest recurring software usage and reporting workload. Furthermore, the segment is set to hold 46.14% share in 2026.

• For instance, in August 2025, CMS updated its Hospital-Acquired Condition (HAC) Reduction Program explicitly ties hospital payment penalties to performance on hospital-acquired conditions.

The AMR & stewardship segment is anticipated to rise with a CAGR of 11.86% over the forecast period.  

By Deployment

Shift Toward Cloud-based Solutions to Boost Cloud/SaaS Segmental Growth

On the basis of deployment, the market is divided into cloud / SaaS and on-premise.

The cloud / SaaS segment dominated the global market in 2025. This dominance is owing to the hospitals wanting faster implementation without procuring and maintaining on-premise servers, databases, and upgrades which is critical when IP/IT teams are already stretched. Moreover, centralized SaaS platforms make it easier to aggregate EHR + lab + pharmacy data across multiple facilities, enabling enterprise dashboards and standardizing infection-prevention workflows across health systems. All these factors support the segment growth. Furthermore, the segment is set to hold 64.42% share in 2026.

• For example, BD is one of the leading providers of cloud solutions for HAI surveillance and near real-time alerts.

The on-premise segment is anticipated to rise with a CAGR of 8.79% over the forecast period.

By End User

Mandatory Surveillance and Reporting Burden Supported Acute Care Hospital Segment Dominance

Based on end user, the market is segmented acute care hospitals, private hospital networks, long-term care, and diagnostic labs & others.

The acute care hospital segment captured the dominating position in the global market. Acute care hospitals manage the highest volumes of invasive procedures, ICU stays, and device utilization which are the major drivers of HAIs such as CLABSI, CAUTI, SSI, MRSA bacteremia, and CDI. These hospitals face the strongest mandatory surveillance and reporting burden, especially in the U.S. where HAI measures are reported to CMS via CDC’s NHSN under hospital quality programs. Furthermore, the segment is set to hold 63.12% share in 2026.

In addition, private hospital networks are projected to grow at a CAGR of 12.03% during the study period.

Infection Surveillance Solutions Market Regional Outlook

By geography, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America infection surveillance solutions market was valued at USD 405.4 million in 2024 and captured the leading position. The region also maintained its leadership in 2025, with USD 421.2 million. The regional dominance is supported by stringent infection control regulations and high healthcare IT adoption. On the other hand, presence of well established companies, and increasing prevalence of HAI in the U.S. has boosted the country’s market growth.

U.S Infection Surveillance Solutions Market

The U.S. market captured the leading position in North American market and can be analytically approximated at around USD 424.4 million in 2026, accounting for roughly 40.8% of global market.

Europe

Europe infection surveillance solutions market size is projected to witness a CAGR of 9.94% in the coming years. The region is anticipated to become the second highest among all regions. The region would reach a market size of USD 274.1 million by 2026. The European market growth is driven by national infection surveillance programs and increasing hospital digitization.

U.K Infection Surveillance Solutions Market

The U.K. infection surveillance solutions market in 2026 is estimated at around USD 40.8 million, representing roughly 3.9% of global revenues.

Germany Infection Surveillance Solutions Market  

Germany infection surveillance solutions market size is projected to reach approximately USD 50.3 million in 2026, equivalent to around 4.8% of global sales.

Asia Pacific

Asia Pacific infection surveillance solutions market size is projected to be valued at USD 182.0 million in 2026 and secure the position of the third-largest region in the global industry. This is driven by expanding healthcare infrastructure and infection control initiatives across Asian countries.

Japan Infection Surveillance Solutions Market

The Japan infection surveillance solutions market in 2026 is estimated at around USD 32.6 million, accounting for roughly 3.1% of global revenues.

China Infection Surveillance Solutions Market

China’s infection surveillance solutions market is projected to reach revenues of around USD 43.7 million in 2026, representing roughly 4.2% of global sales.

India Infection Surveillance Solutions Market

The India infection surveillance solutions market in 2026 is estimated at around USD 18.8 million, accounting for roughly 1.8% of global revenues.

Latin America and Middle East & Africa

The Latin America and Middle East and Africa regions would witness a slower growth rate in this market space. The Latin America infection surveillance solutions market size is set to reach a valuation of USD 0.55 million in 2026. These regions are anticipated to grow in near future owing to an increase in infection cases, and other factors.

Brazil Infection Surveillance Solutions Market

The Brazil infection surveillance solutions market is projected to reach around USD 0.02 billion in 2025, representing roughly 2.11% of global infection surveillance solutions revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Focus on Strategic Initiatives by Leading Market Players to Strengthen Market Share

The global market for infection surveillance solutions is moderately consolidated in competitiveness. The market is dominated by leading companies Premier Inc., Oracle, BD, and others accounting for significant shares in the global market. This can be attributed to their strong geographic presence, broad product portfolios, and focus on technological advancements.

Other key players in the infection surveillance solutions market include Wolters Kluwer N.V., Baxter, Epic Systems Corporation, and others. Collaborations & partnerships, new product development, and product enhancements are some of the strategies undertaken by these players to gain market share.

LIST OF KEY INFECTION SURVELLIENCE SOLUTIONS COMPANIES PROFILED

• BD (U.S.)
• Premier Inc. (U.S.)
• Wolters Kluwer N.V. (The Netherlands)
• Clinisys, Inc. (U.S.)
• Oracle (U.S.)
• GOJO Industries, Inc. (U.S.)
• Baxter (U.S.)
• (U.S.)
• RLDatix. (U.S.)
• Epic Systems Corporation (U.S.)

KEY INDUSTRY DEVELOPMENTS

• October 2025: BD updated multiple HealthSight Infection Advisor with MedMined Insights workflow/training materials, which reflects ongoing product improvements and user enablement.
• July 2025: Ireland’s eHealth Ireland announced a National Clinical Surveillance IT System for infection prevention/control using Baxter’s ICNET.
• June 2025: Wolters Kluwer N.V launched extensive updates to Sentri7 solution, reinforcing ongoing investment in the clinical surveillance platform used by infection prevention teams.
• February 2025: Wolters Kluwer N.V. announced that its Sentri7 solutions was named Best in KLAS (2025) for Infection Control & Monitoring.
• February 2024: Inovalon announced that its VigiLanz solution ranked first by KLAS for Infection Control & Monitoring.

REPORT COVERAGE

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation